Semnur Pharmaceuticals to go public in SPAC deal of up to $2 billion with Denali Capital-March 2024-www.financetom.com

Semnur Pharmaceuticals to go public in SPAC deal of up to $2 billion with Denali Capital

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Semnur Pharmaceuticals to go public in SPAC deal of up to $2 billion with Denali Capital

Jul 2, 2024 3:07 PM

July 2 (Reuters) - Drug developer Semnur Pharmaceuticals

said on Tuesday it has signed a letter of intent to go public

through a merger with special purpose acquisition company Denali

Capital Acquisition Corp ( DECA ) in a pre-transaction equity

deal valued at up to $2 billion.

Semnur is a unit of Scilex Holding ( SCLX ).

Previous page： Bank of Nova Scotia Q2 Results Neutral, CIBC Says, Dividend and CET1 Ratio Notable Next page： Definitive Healthcare Hires Kevin Coop as CEO

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Bank of Nova Scotia Q2 Results Neutral, CIBC Says, Dividend and CET1 Ratio Notable

May 28, 2024

08:33 AM EDT, 05/28/2024 (MT Newswires) -- Bank of Nova Scotia's ( BNS ) dividend and Common Equity Tier 1 (CET1) ratio were notable elements of its Q2 results, CIBC Capital Markets said on Tuesday. The Canadian bank reported quarterly earnings before market open, and CIBC analyst Paul Holden said the results were neutral with in-line EPS and most key...

Definitive Healthcare Hires Kevin Coop as CEO

May 28, 2024

08:34 AM EDT, 05/28/2024 (MT Newswires) -- Definitive Healthcare ( DH ) said Tuesday that it has appointed Kevin Coop to succeed Jason Krantz as its chief executive officer, effective June 24. Krantz, who has served as interim CEO since January, will remain on the board as executive chairman following the CEO transition. Coop has previously served as CEO of...

FSD Pharma Slightly Lower In US Premarket As Submits Clinical Trial Protocol to Study Safety and Efficacy of Unbuzzd in Acute Alcohol Intoxication

May 28, 2024

08:36 AM EDT, 05/28/2024 (MT Newswires) -- FSD Pharma ( HUGE ) on Tuesday said it has submitted a clinical trial protocol to the Institutional Review Board (IRB) in the U.S. to assess the safety and efficacy of Unbuzzd in healthy volunteers in the METAL-2 trial. Recruitment of healthy volunteers will begin following approval. In the METAL-2 trial, the ability...

Update: T-Mobile to Acquire US Cellular's Wireless Operations, Select Spectrum Assets in $4.4 Billion Deal

May 28, 2024

08:33 AM EDT, 05/28/2024 (MT Newswires) -- (Updates with additional details) T-Mobile US ( TMUS ) has entered into a definitive agreement with United States Cellular ( USM ) and Telephone and Data Systems ( TDS/PV ) to acquire UScellular's wireless operations and select spectrum assets in a deal valued at $4.4 billion, including a combination of cash and up...